Tong Wei W - OmicsDI

Show results for

Unknown (959)
Proteomics (51)
Transcriptomics (15)
Multiomics (6)
Metabolomics (6)
Genomics (2)

Organisms

Homo sapiens (30)
Mus musculus (15)
Andropogon gerardi (10)
Bacteria (10)
Canis lupus familiaris (10)
Cnidaria (10)
Cricetulus griseus (10)
Eukaryota (10)
Fasciola (10)
Hepatitis B virus (10)
Human betaherpesvirus 5 (10)
Madurella mycetomatis (10)
Mesocricetus auratus (10)
Miscanthus x giganteus (10)
Mus musculus (10)
Mycobacterium tuberculosis (10)
Orthoflavivirus (10)
Panicum virgatum (10)
Platyhelminthes (10)
Pseudomonas aeruginosa AES-1R (10)
Rattus norvegicus (10)
Rattus rattus (10)
Rhodococcus jostii RHA1 (10)
Saccharomyces cerevisiae (10)
Escherichia coli (5)
Mycobacterium tuberculosis H37Rv_2009 (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Hypophthalmichthys nobilis (1)
Chlorocebus sabaeus (1)
Rattus norvegicus (1)

Repository

iProX (35)
biostudies-arrayexpress (15)
pride (10)
MetaboLights (6)
MassIVE (3)
PeptideAtlas (3)
EGA (2)

Tissue

Others (3)
Cell culture (3)
Brain (1)
Early embryonic cell (1)
Epithelial cell (1)
Glomerular visceral epithelial cell (1)
Leaf (1)
Lung (1)
Permanent cell line cell (1)
Plant cell (1)
Renal cortical epithelial cell (1)
Skin (1)
Thymic epithelium (1)

Disease

Lung benign neoplasm (1)

Technology Type

Mass Spectrometry (10)
Shotgun proteomics (6)
Mass spectrometry assay (3)
Affinity purification coupled with mass spectrometry proteomics (3)
Mass spectrometry (2)
NMR spectroscopy (1)
Bottom-up proteomics (1)
MSE (1)
SRM/MRM (1)

Instrument Platform

MS:1000031 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (2)
LTQ Orbitrap Elite (2)
Illumina HiSeq 2500 (1)
Bruker (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
QExactive (1)

Publication Date

2021 (13)
2020 (8)
2016 (7)
2022 (7)
2014 (6)
2024 (6)
2025 (5)
2026 (4)
2023 (4)
2015 (3)
2013 (2)
2019 (2)
2017 (1)
2012 (1)
2011 (1)
2010 (1)
2008 (1)

UNIPROT ID/AC

A0A024R563 (3)
A0A024R8H9 (3)
A0A024RAN2 (3)
A0A024RC46 (3)
A0A087WUD1 (3)
A0A087WVZ5 (3)
A0A087WWK8 (3)
A0A087WXI0 (3)
A0A087WZE9 (3)
A0A087X1S3 (3)
A0A0A0MR66 (3)
A0A0A0MS51 (3)
A0A0A0MSA7 (3)
A0A0B4J220 (3)
A0A0C4DG89 (3)
A0A0C4DGT3 (3)
A0AV96 (3)
A0AVT1 (3)
A0FGR8 (3)
A0FGR8-2 (3)
A0FGR8-6 (3)
A0JLT2 (3)
A0JNW5 (3)
A0MZ66 (3)
A0PJW6 (3)
A0PK00 (3)
A1A4S6 (3)
A1L0T0 (3)
A1L170 (3)
A1L390 (3)

ENSEMBL ID

ENSG00000147251 (3)
ENSG00000170477 (3)
ENSG00000247315 (3)

CHEBI ID

CHEBI:50129 (2)
CHEBI:60645 (2)
CHEBI:16755 (2)
CHEBI:9907 (2)
CHEBI:30751 (2)
CHEBI:16525 (2)
CHEBI:30794 (2)
CHEBI:30746 (2)
CHEBI:1148 (2)
CHEBI:17859 (2)
CHEBI:28834 (2)
CHEBI:16359 (2)
CHEBI:32806 (2)
CHEBI:30768 (2)
CHEBI:15741 (2)
CHEBI:15611 (2)
CHEBI:15428 (2)
CHEBI:18012 (2)
CHEBI:30915 (2)
CHEBI:9410 (2)
CHEBI:28865 (2)
CHEBI:18089 (2)
CHEBI:30769 (2)
CHEBI:20067 (2)
CHEBI:53492 (1)
CHEBI:91029 (1)
CHEBI:229942 (1)
CHEBI:167175 (1)
CHEBI:192304 (1)
CHEBI:138489 (1)

Metabolite Name

Picolinic acid (2)
4-Hydroxyphenylpyruvic acid (2)
3-Methyl-2-oxovaleric acid (2)
2-Hydroxy-3-methylbutyric acid (2)
Glycine (2)
Methylsuccinic acid (2)
3-Hydroxyisovaleric acid (2)
L-Alanine (2)
Glycolic acid (2)
Ursodeoxycholic acid (2)
Oxoadipic acid (2)
Benzoic acid (2)
Taurine (2)
Taurocholic acid (2)
Deoxycholic acid (2)
Cholic acid (2)
Stearic acid (2)
Pentadecanoic acid (2)
Arachidonic acid (2)
Oxoglutaric acid (2)
Citric acid (2)
Isocitric acid (2)
Glyceric acid (2)
Suberic acid (2)
Sarcosine (2)
Glutaric acid (2)
Adipic acid (2)
Methylmalonic acid (2)
Myristic acid (2)
L-Serine (2)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (3)
ChIP-chip by tiling array (1)
RNA-seq of non coding RNA (1)

Release Date

2025 (179)
2022 (130)
2023 (126)
2024 (119)
2021 (97)
2020 (69)
2019 (57)
2018 (38)
2017 (35)
2015 (29)
2026 (29)
2016 (25)
2013 (11)
2014 (10)
2012 (7)
2010 (3)
2008 (3)
2011 (2)
2006 (2)
2009 (1)
2005 (1)
2004 (1)

Lab affiliation

Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, People’s Republic of China; Research Unit of key techniques for treatment of burns and combined burns and trauma injury, Chinese Academy of Medical Sciences, Shanghai, China. (1)
Department of Medicine, Nephrology and Pharmacological Sciences, Icahn School of Medicine at Mount Sinai (1)
Hospital for Sickkids, University of Toronto (1)
Institute of Interdisciplinary Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China (1)
John Cijiang He, MD/PhD Division of Nephrology, Box 1243 Mount Sinai School of Medicine One Gustave L Levy Place, New York NY 10029 Tel: 212-659-1703, Fax: 212-987-0389 (1)
Lab of Proteomics, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China. (1)
Program in Cell Biology Hospital For Sick Children, Toronto, SPARC BioCentre Hospital For Sick Children, Toronto, 8Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (1)
Program in Cell Biology, SPARC BioCentre, Hospital For Sick Children, Toronto; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. (1)
Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, China. (1)
state key lab of rice biology china national rice research institute (1)

Previous page
1 / 104
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 104
Next page

Sort by:

Relevance

Page size

Heart specific moderate over-expression of serum response factor (SRF) in 6mo mouse.

To identify in vivo new cardiac SRF target genes and to study the response of these novel genes to SRF overexpression, we employed a cardiac-specific, transgenic mouse model that has a phenotype in young adulthood which resembles that of the typically aged heart. Using this “cardiac aging” model, we...

ORGANISM(S): Mus musculus

2011-08-02 | E-GEOD-19874 | biostudies-arrayexpress

Proteomics and metabolomics reveal changes in cancer cells after alternation of SHMT2 expressions

In order to understand the underline mechanism of SHMT2 (serine hydroxymethyltransferase 2) effect on tumor growth, proteome and metabolome analysis were carried on a engineered HeLa cell line (HeLa-SHMT2-shSHMT2, short as HeLa-Ss), which has inducible SHMT2 over-expression or suppression by treatin...

ORGANISM(S): Homo sapiens (Human)

2020-08-19 | PXD004954 | Pride

Huo Xue Tong Luo capsule, a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head: A prospective study.

Not available

S-EPMC6718872 | biostudies-literature

Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers.

Not available

S-EPMC9967631 | biostudies-literature

Cancer proteome and metabolite changes linked to SHMT2

To screen for proximate and interacting proteins of SHMT2 in HeLa cells, the BioID method was employed, which consists of biotinylation of proteins in the vicinity of FlagBirAR118G –SHMT2 followed by streptavidin-based affinity capture and mass spectrometry identification. Experimental procedures we...

ORGANISM(S): Homo sapiens (Human)

2020-08-12 | PXD004629 | Pride

Streptavidin Shmt2 Ms Bioid

Longitudinal Microstructural Changes in Traumatic Brain Injury in Rats: A Diffusional Kurtosis Imaging, Histology, and Behavior Study.

Not available

S-EPMC7655293 | biostudies-literature

METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.

Not available

S-EPMC9744165 | biostudies-literature

Association of Genetic Variants of SIRT1 With Type 2 Diabetes Mellitus.

Not available

S-EPMC8750030 | biostudies-literature